Biological Properties of ICRF-159 and Related Bis(dioxopiperazine) Compounds
- 1 January 1982
- book chapter
- Published by Elsevier
- Vol. 19, 249-290
- https://doi.org/10.1016/s1054-3589(08)60025-3
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Synthesis and antimetastatic properties of stereoisomeric tricyclic bis(dioxopiperazine) analogs in a B16 melanoma modelJournal of Medicinal Chemistry, 1981
- Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159The Prostate, 1981
- The effects of α-tocopherol on the toxicity, disposition, and metabolism of adriamycin in miceToxicology and Applied Pharmacology, 1979
- ICRF-159: Current status and clinical prospectsEuropean Journal of Cancer (1965), 1977
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- The effect of (±) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphomaEuropean Journal of Cancer (1965), 1975
- Biochemical studies on growth‐inhibitory bisdioxopiperazines. I. Effect on dna, rna and protein synthesis in mouse‐embryo fibroblastsInternational Journal of Cancer, 1970
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969
- An experimental model for studying factors which influence metastasis of malignant tumorsInternational Journal of Cancer, 1967
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967